about
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial.Calreticulin exposure dictates the immunogenicity of cancer cell deathThe receptor NLRP3 is a transcriptional regulator of TH2 differentiationBleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cellsProspective study of the evolution of blood lymphoid immune parameters during dacarbazine chemotherapy in metastatic and locally advanced melanoma patientsActivation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumorsThe intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsTim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells.Liver X receptor β activation induces pyroptosis of human and murine colon cancer cellsEnterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalType 1 regulatory T cells (Tr1) in autoimmunityInduction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.Consensus nomenclature for CD8(+) T cell phenotypes in cancerPhenolic extract from oleaster (Olea europaea var. Sylvestris) leaves reduces colon cancer growth and induces caspase-dependent apoptosis in colon cancer cells via the mitochondrial apoptotic pathway.Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.Human ectonucleotidase-expressing CD25(high) Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions.The anticancer immune response: indispensable for therapeutic success?Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients.Links between innate and cognate tumor immunity.Metallothioneins negatively regulate IL-27-induced type 1 regulatory T-cell differentiation.CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer.Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic.Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?Ecto-calreticulin in immunogenic chemotherapy.The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.Molecular characteristics of immunogenic cancer cell death.Immunological aspects of cancer chemotherapy.Immunogenicity of anthracyclines: moving towards more personalized medicine.Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity.Protection against malaria in mice is induced by blood stage-arresting histamine-releasing factor (HRF)-deficient parasitesMolecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies.Immunogenic cancer cell death: a key-lock paradigm.
P50
Q27851740-3C07099A-F4A9-478D-A500-BB259EF8EDF6Q28280438-23684B86-6126-4464-AC2B-8886EE49EB25Q28512758-11A20FAC-EA54-45EB-884D-D1B738FC12DEQ28533749-04DC14E7-5535-49C4-9DDA-951DA614ADC8Q28542660-BA160FBA-F0E3-4934-A1D0-1BE80D9EC82AQ29615665-C3E4AD4C-6F54-4C7C-8F6F-D6C1B08D8DE0Q31144277-749C400F-FFAE-4972-A9D9-DAC2377AD520Q33604925-1D589396-24AB-49D4-BE75-66BBA592B44BQ34078014-488A0546-A66A-420C-94C4-6DD4424CF662Q34131656-965FA4D2-121A-424C-91EF-4253F45C0DA7Q34161493-58810AAE-D276-408D-AB63-B5D5F5D22114Q34242160-2DCEB5CD-8046-4F3C-8B23-4B0BB6ED6801Q34486432-3B9E3320-E4EC-4578-85AB-1076ABA77865Q34542239-C63FE57B-19BB-46BC-8F68-6D53E01A25DDQ34681370-D963B012-CD60-469B-839C-E8F3331D63FDQ35212682-60EA1928-BD13-49DF-8C57-754F15D2472EQ35226496-BD956EFA-9106-4571-ACF5-249C732ACA81Q35592657-7FE6561E-73C3-4B64-8175-CBBF1FC0FBE0Q35798822-E57CF1C2-5705-4859-A63C-AFFC1E2DCE26Q36284206-7937DA4E-F8F5-41F4-A618-47B528B79075Q36301061-D9B71994-3FE9-4C23-9CDA-56C6BF5EEEE3Q36549279-07208282-1461-463C-8625-9159B11996D9Q36597320-6F7D155C-DE43-4EBD-8B16-C7E443450E8EQ36677608-DD169654-D94D-467B-84BA-F9F28DFBBB6FQ36710911-AF188CDE-018F-49B0-B219-C1AB53FFAFF4Q36736618-F522EE0C-B3F9-4514-9456-36BDCBEB3510Q36835441-47D8015C-B189-4B73-8CD0-BA644136F943Q36915014-4B52ECC5-F938-4137-BE85-3CADD762453CQ36931431-37A1FEAA-436C-46E5-82B8-2873AE5B2F78Q36949870-A1813A3F-7A6C-4BAA-8FC8-E8A8C01E6BD9Q36962594-C37C08D0-B956-4A3A-86F2-1CB16B97A686Q36990570-A67591B7-28E0-4FCA-86D0-5779BF0F3FEDQ36990578-606B8D6F-51A2-4B34-A284-1C0F703E85E2Q37002804-36B2655B-23A5-419E-A1E5-7DDF9ECCC994Q37039588-F5763C92-3C9F-477E-99D2-62C01FDD09D2Q37114351-44389726-FEC4-4FB9-8000-A7D0750AD023Q37120261-DB3A0D1F-7C46-4812-B058-669FA9C557C0Q37179042-2C91654B-ECFF-49E8-AAC0-2EB5BCF7D1DDQ37179972-17C87083-80FF-4711-8228-FF8EE6A567C3Q37198125-6B476A60-BD41-44D2-A7CF-BB4F38390E9A
P50
description
hulumtues
@sq
immunoloog
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Lionel Apetoh
@ast
Lionel Apetoh
@en
Lionel Apetoh
@es
Lionel Apetoh
@fr
Lionel Apetoh
@sl
type
label
Lionel Apetoh
@ast
Lionel Apetoh
@en
Lionel Apetoh
@es
Lionel Apetoh
@fr
Lionel Apetoh
@sl
prefLabel
Lionel Apetoh
@ast
Lionel Apetoh
@en
Lionel Apetoh
@es
Lionel Apetoh
@fr
Lionel Apetoh
@sl
P214
P227
P269
P1053
G-3310-2014
P106
P1153
55914123700
P1412
P21
P214
P227
1120736447
P269
P27
P2798
P31
P3829
P496
0000-0002-2774-438X
P569
1981-08-13T00:00:00Z
P6634
lionel-apetoh-9794149b
P735
P7859
viaf-188652572